Lymphoma
Lymphoma
Advertisement
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | October 15, 2024
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
View More
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOHematology & Blood Cancer | September 18, 2024
Hear about an NP's journey into hematologic oncology and how she has seen the treatment landscape evolve.
Cecilia BrownLymphoma | July 29, 2024
It's the first subcutaneously administered T-cell engaging bispecific antibody approved in the US to treat these patients.
Lorna WarwickLymphoma | July 3, 2024
Lorna Warwick discusses how nurses can connect patients with resources from the coalition and its member organizations.
Lorna WarwickConferences | July 1, 2024
Lorna Warwick, CEO of Lymphoma Coalition, discusses how nurses can strengthen bonds with patients through communication.
Lorna WarwickConferences | June 26, 2024
Lorna Warwick discusses the important role that nurses serve in ensuring patients receive care and information.
Lorna WarwickConferences | June 15, 2024
Ms. Warwick discusses what nurses should know about results from the coalition's global patient survey.
Cecilia BrownHematology & Blood Cancer | April 16, 2024
Educational content focused on the pre-HSCT work-up process, chemotherapy, and transplant admission expectations.
Cecilia BrownHematology & Blood Cancer | March 6, 2024
Nurses reported that they were “keenly aware of how disruptive the environment is for patients and their families."
Cecilia BrownGU Cancer | February 1, 2024
Psychosocial care and support are critical parts of cancer care, according to the International Psycho-Oncology Society.
Cecilia BrownHematology & Blood Cancer | January 15, 2024
Researchers developed and piloted a novel phone-delivered positive psychology intervention called PATH.
Dustin SamplesConferences | October 17, 2023
Accelerated approvals will no longer be granted based on overall response rates in single-arm trials.
Dustin SamplesLymphoma | October 17, 2023
A case series demonstrated the effectiveness of a novel trio for pediatric plasmacytic PTLD.
Leah LawrenceTreatment | October 17, 2023
A recently approved TIW schedule provides new option for patients with ALL or LBL receiving asparaginase.
Dustin SamplesHematology & Blood Cancer | October 17, 2023
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Patrick DalyLymphoma | October 17, 2023
Robert E. Brown, MD, and collaborating researchers from the University of Texas Health Science Center at Houston McGovern ...
Patrick DalyLymphoma | October 17, 2023
A study published in the Journal of Cancer Research and Clinical Oncology discussed outcomes of anti-CD20-based combination ...
Patrick DalyLymphoma | October 17, 2023
Data on diffuse large B-cell lymphoma (DLBCL) from the OncoCollect Lymphoma group registry were recently published in ...
Patrick DalyLymphoma | October 17, 2023
A study published in European Radiology examined the prognostic efficacy of automatic segmentation of diffuse large B-cell ...
Patrick DalyLymphoma | October 17, 2023
According to a study published in the International Journal of Radiation Oncology, Biology, Physics, approximately 50% of ...
Advertisement
Advertisement
Advertisement